Affordable Access

deepdyve-link
Publisher Website

Serial evaluation of CD19 surface expression in pediatric B-cell malignancies following CD19-targeted therapy.

Authors
  • Libert, Diane1
  • Yuan, Constance M2
  • Masih, Katherine E3
  • Galera, Pallavi2
  • Salem, Dalia2
  • Shalabi, Haneen1
  • Yates, Bonnie1
  • Delbrook, Cindy1
  • Shern, Jack F1
  • Fry, Terry J1, 4
  • Khan, Javed3
  • Stetler-Stevenson, Maryalice2
  • Shah, Nirali N5
  • 1 Pediatric Oncology Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), NIH, Bethesda, MD, USA.
  • 2 Laboratory of Pathology, CCR, NCI, NIH, Bethesda, MD, USA.
  • 3 Oncogenomics Section, Genetics Branch, CCR, NCI, NIH, Bethesda, MD, USA.
  • 4 Division of Human Immunology and Immunotherapy Initiative, Pediatric Hematology/Oncology, Children's Hospital of Colorado, Aurora, CO, USA.
  • 5 Pediatric Oncology Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), NIH, Bethesda, MD, USA. [email protected]
Type
Published Article
Journal
Leukemia
Publisher
Springer Nature
Publication Date
Nov 01, 2020
Volume
34
Issue
11
Pages
3064–3069
Identifiers
DOI: 10.1038/s41375-020-0760-x
PMID: 32103145
Source
Medline
Language
English
License
Unknown
Report this publication

Statistics

Seen <100 times